Sunflower Bank, N.A. Provectus Biopharmaceuticals, Inc. Transaction History

Sunflower Bank, N.A.

  • $364 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 13, 2022
SELL
$0.05 - $0.07 $120,593 - $168,830
-2,411,871 Closed
0 $0
Q4 2021

Sep 13, 2022
BUY
$0.05 - $0.06 $120,593 - $144,712
2,411,871 New
2,411,871 $133,000

Others Institutions Holding PVCT

# of Institutions
7
Shares Held
227K
Call Options Held
0
Put Options Held
0
View Full List

About PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT Quotes by TradingView
  • Ticker PVCT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 419,496,992
  • Market Cap $54.5M
  • Description
  • Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...
More about PVCT
Track This Portfolio

Track Sunflower Bank, N.A. Portfolio

Follow Sunflower Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunflower Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Sunflower Bank, N.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email